HDAC5, a potential therapeutic target and prognostic biomarker, promotes proliferation, invasion and migration in human breast cancer. - Wikidata - wikimedia - TriplyDB

HDAC5, a potential therapeutic target and prognostic biomarker, promotes proliferation, invasion and migration in human breast cancer.

HDAC5, a potential therapeutic target and prognostic biomarker, promotes proliferation, invasion and migration in human breast cancer.

http://www.wikidata.org/entity/Q37437368

about

Multidimensional pooled shRNA screens in human THP-1 cells identify candidate modulators of macrophage polarization.Histone Deacetylases as New Therapeutic Targets in Triple-negative Breast Cancer: Progress and Promises HDAC inhibitor LMK‑235 promotes the odontoblast differentiation of dental pulp cells.Molecular regulation of epithelial-to-mesenchymal transition in tumorigenesis (Review).Overexpression of HDAC9 is associated with poor prognosis and tumor progression of breast cancer in Chinese females.Anti-tumor activity of phenoxybenzamine and its inhibition of histone deacetylases.Neutralizing negative epigenetic regulation by HDAC5 enhances human haematopoietic stem cell homing and engraftment.

P2860

Q38694268-9CCC9F4C-EAEA-44C5-91D8-DC89F13A3F07 Q41664067-48B1B31E-71AD-4C6D-AAF3-7D08BD3E750F Q47401089-CA6FD4EC-8C6B-45F4-A204-5699A7A94CE1 Q49501076-E6459755-7321-400F-9363-7BBC494E62AC Q54090659-FF48782D-4977-4B9A-9500-C2D492430FBE Q55227907-747AFC92-59C0-41FF-B47B-BB75F5C8D910 Q55717745-9C352195-E7EC-42DE-A98C-C43957B4A2E4

P2860

HDAC5, a potential therapeutic target and prognostic biomarker, promotes proliferation, invasion and migration in human breast cancer.

http://www.wikidata.org/entity/Q37437368

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 10 May 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

HDAC5, a potential therapeutic ...... ration in human breast cancer.

@en

HDAC5, a potential therapeutic ...... ration in human breast cancer.

@nl

type

label

HDAC5, a potential therapeutic ...... ration in human breast cancer.

@en

HDAC5, a potential therapeutic ...... ration in human breast cancer.

@nl

prefLabel

HDAC5, a potential therapeutic ...... ration in human breast cancer.

@en

HDAC5, a potential therapeutic ...... ration in human breast cancer.

@nl

P1433

Q37437368-261477AC-75AA-451E-AA8F-2B26798DA083

P1476

Q37437368-B7D44E5B-87E2-4798-B62B-2851BB8FD52E

P2093

Q37437368-3482F0BC-460D-45C5-B9FB-8544D46D53B8

Q37437368-391350CE-EE84-400A-ADAD-F67F8B5D213C

Q37437368-5D7D3DC5-367C-4A34-A62E-C493037609A7

Q37437368-A40BD763-BE66-4F74-BA79-DC21FD4C1952

Q37437368-B14D156E-B82F-4827-B0CD-696144E8FB3E

Q37437368-C4185D22-4950-4B3E-898F-F72ED3745BCF

Q37437368-DEE58932-6B2B-4767-B245-B55C7FE0F3B7

P2860

Q37437368-08D13B20-66BD-4E1A-813E-038B144DFF59

Q37437368-1185D94C-8ACD-4F3B-9CF3-6E165E4F2721

Q37437368-147EAA21-4BC9-4D6C-B31A-08EE7CCE284E

Q37437368-1EE4C2EC-F3BB-4157-8978-52970A09199A

Q37437368-340E5EE4-3DD1-40FD-92FD-3CDD3B5067ED

Q37437368-46F52D41-25D3-4198-BEB7-BA35269135C6

Q37437368-481E5E4B-8069-498F-99C0-72EB90C1DB33

Q37437368-4D5B62F1-93B1-4502-910C-C29B80FE93E0

Q37437368-50ACB853-4C0A-4A95-950B-68EA9463F551

Q37437368-7473844F-1E65-4E59-9535-496FA9361C36

P304

Q37437368-8DEF61CD-21CB-48FD-88AC-F16E94BD01FF

P31

Q37437368-E18BAFE4-DCAA-4108-B03C-70BEF7D6045E

P356

Q37437368-DB4460A6-29FB-4F16-808B-A54C79999D62

P407

Q37437368-1B64FE7F-733D-44C9-8772-19469E91A0DB

P433

Q37437368-3E06E043-B91B-4B6D-8A66-6879C60D6DE2

P478

Q37437368-B866C533-4F06-4272-AE96-B0FAD4FFEDA4

P577

Q37437368-6CEE4AE5-9D91-4D40-9C0B-4845C1EB8514

P698

Q37437368-799935F1-E721-4B26-8D36-7312FD2DF8B2

P921

Q37437368-C1BEA592-9DB0-416E-8481-9B395F8EC6C1

P932

Q37437368-626AAE5B-6F61-44DF-A6E4-390E054E9EC2

P356

ONCOTARGET.9274

P1433

P1476

HDAC5, a potential therapeutic ...... ration in human breast cancer.

@en

P2093

Anqi Li

http://www.w3.org/2001/XMLSchema#string

Ming Li

http://www.w3.org/2001/XMLSchema#string

Shuling Zhou

http://www.w3.org/2001/XMLSchema#string

Wentao Yang

http://www.w3.org/2001/XMLSchema#string

Yan Xu

http://www.w3.org/2001/XMLSchema#string

Yaoxing Xiao

http://www.w3.org/2001/XMLSchema#string

Zebing Liu

http://www.w3.org/2001/XMLSchema#string

P2860

Signal-dependent nuclear export of a histone deacetylase regulates muscle differentiation

Aurora A Kinase Inhibition Selectively Synergizes with Histone Deacetylase Inhibitor through Cytokinesis Failure in T-cell Lymphoma.

Anticancer activities of histone deacetylase inhibitors

Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies

Tissue microarrays for high-throughput molecular profiling of tumor specimens

Differential expression of selected histone modifier genes in human solid cancers.

Reduced expression of class II histone deacetylase genes is associated with poor prognosis in lung cancer patients.

mTORC1/C2 and pan-HDAC inhibitors synergistically impair breast cancer growth by convergent AKT and polysome inhibiting mechanisms.

Targeting class I histone deacetylase 2 in MYC amplified group 3 medulloblastoma.

HDAC inhibitors target HDAC5, upregulate microRNA-125a-5p, and induce apoptosis in breast cancer cells

P304

37966-37978

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.9274

http://www.w3.org/2001/XMLSchema#string

P407

P433

25

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P577

2016-05-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27177225

http://www.w3.org/2001/XMLSchema#string

P921

P932

5122364

http://www.w3.org/2001/XMLSchema#string